Search
Accenture > Find this article at:
- 4 min
Turning science into value: Biopharma high performance business research
Biopharmaceutical companies focused on patient outcomes are enjoying more commercial success and outperforming their peers. Our research found that the biopharmaceutical companies focused on patient outcomes are enjoying more commercial success and outperforming their peers. In fact, a wave of new science has driven the output of new drug launches to levels not seen since the mid-1990s. Since Accenture’s last High Performance Business (HPB) Study of the Pharmaceutical Sector,
by Geoffrey Pullum / The chronicle of higher
- 3 min
Unspeakable Drug Names
Capecitabine (C15H22FN3O6) is an oncologically important chemotherapeutic prodrug. It has a trade name: Xeloda (pronounced zee-ló-da, I presume). And it’s just as well, because capecitabine is a train wreck of a name. The normal principles for interpreting English orthography come nowhere near determining even an approximate pronunciation. Try saying capecitabine aloud before you read on. How would you pronounce it, for example, in a lecture? Do you dare to even hazard a gues
